Home › Funds › Vivo Capital, LLC › TENX
Vivo Capital, LLC position in TENX
TENAX THERAPEUTICS INC · Health Care
Vivo Capital, LLC reported holding 2,500,000 shares of TENX (TENAX THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$4.7M, representing 0.54% of its reported portfolio and ranking #39 among its reported holdings. Vivo Capital, LLC has disclosed TENX holdings in 9 of the last 9 reported quarters, going back to Q3 2024.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Vivo Capital, LLC's TENX position evolved
Vivo Capital, LLC first disclosed a stake in TENX in Q3 2024 at 208,333 shares (US$721K). The position peaked in Q2 2026 at 2,500,000 shares, worth US$36.4M. Across 9 filings, Vivo Capital, LLC increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 7 time(s). The most recent filing (Q3 2026) shows 2,500,000 shares valued at US$4.7M. Notable position changes include a 1100% increase in Q2 2026 (shares fell 87% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2024 | 208.33K | $720.83K | New |
| Q4 2024 | 208.33K | $1.29M | Hold |
| Q1 2025 | 208.33K | $1.36M | Hold |
| Q2 2025 | 208.33K | $1.20M | Hold |
| Q3 2025 | 208.33K | $1.59M | Hold |
| Q4 2025 | 208.33K | $2.54M | Hold |
| Q1 2026 | 208.33K | $3.33M | Hold |
| Q2 2026 | 2.50M | $36.38M | Add |
| Q3 2026 | 2.50M | $4.72M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About TENX and 13F data
TENX (TENAX THERAPEUTICS INC) is a Health Care company. 77 other funds we track also report a position in TENX — the largest reported positions include Stonepine Capital Management, LLC (US$9.6M), Sofinnova Investments, Inc. (US$7.3M), BVF INC/IL (US$4.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding TENX
- Stonepine Capital Management, LLC 660.00K sh · $9.60M · Q2 2026
- Sofinnova Investments, Inc. 500.04K sh · $7.28M · Q2 2026
- BVF INC/IL 339.55K sh · $4.94M · Q2 2026
- DIADEMA PARTNERS LP 307.00K sh · $4.47M · Q2 2026
- Avidity Partners Management LP 265.93K sh · $3.87M · Q2 2026
- Verdad Advisers, LP 123.17K sh · $1.79M · Q2 2026
- Tetragon Partners GP Ltd 75.10K sh · $1.09M · Q2 2026
- Velan Capital Investment Management LP 68.70K sh · $999.59K · Q2 2026
- Artia Global Partners LP 42.08K sh · $612.26K · Q2 2026
- Jones Hill Capital LP 122.17K sh · $230.90K · Q3 2026
More on Vivo Capital, LLC
FAQ
How long has Vivo Capital, LLC held TENX?
Vivo Capital, LLC has disclosed TENX holdings in 9 of the last 9 reported quarters, going back to Q3 2024.
What is Vivo Capital, LLC's current position in TENX?
As of Q3 2026, Vivo Capital, LLC holds 2.50M shares of TENX (TENAX THERAPEUTICS INC), valued at $4.72M, representing 0.54% of its reported portfolio and ranking #39.
Has Vivo Capital, LLC been buying or selling TENX?
In the latest 13F filing (Q3 2026), Vivo Capital, LLC held unchanged its position in TENX. The position peaked in Q2 2026 at 2.50M shares.
Which other funds hold TENX?
Other major institutional holders of TENX include Stonepine Capital Management, LLC, Sofinnova Investments, Inc., BVF INC/IL, among 77 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.